311 related articles for article (PubMed ID: 33626447)
21. Performance Characteristics of Mass Spectrometry-Based Analytical Procedures for Quantitation of Nitrosamines in Pharmaceuticals: Insights from an Inter-laboratory Study.
Yang J; Kakarla R; Marzan T; Sherwin B; George M; Bennett J; Basutto J; Su Y; Ollerenshaw J; Morin J; Rebière H; Maggio AF; Kermaïdic A; Gervela E; Brenier C; Civade C; Chauvey D; Duperray F; Wollein U; Conti M; Tromp J; Meyer S; Wanko R; Wierer M; Bertrand M; Rodriguez J; Sommers C; Keire D
J Pharm Sci; 2023 Oct; 112(10):2685-2695. PubMed ID: 37524228
[TBL] [Abstract][Full Text] [Related]
22. Analytical Method Lifecycle Management in Pharmaceutical Industry: a Review.
Volta E Sousa L; Gonçalves R; Menezes JC; Ramos A
AAPS PharmSciTech; 2021 Apr; 22(3):128. PubMed ID: 33835304
[TBL] [Abstract][Full Text] [Related]
23. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
[TBL] [Abstract][Full Text] [Related]
24. Ion exchange in supercritical fluid chromatography tandem mass spectrometry (SFC-MS/MS): Application for polar and ionic drugs and metabolites in forensic and anti-doping analysis.
Xhaferaj M; Naegele E; Parr MK
J Chromatogr A; 2020 Mar; 1614():460726. PubMed ID: 31787266
[TBL] [Abstract][Full Text] [Related]
25. Development of a new methodology for the determination of N-nitrosamines impurities in ranitidine pharmaceuticals using microextraction and gas chromatography-mass spectrometry.
Giménez-Campillo C; Pastor-Belda M; Campillo N; Hernández-Córdoba M; Viñas P
Talanta; 2021 Feb; 223(Pt 2):121659. PubMed ID: 33298254
[TBL] [Abstract][Full Text] [Related]
26. Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography-tandem mass spectrometry.
Yamamoto E; Kan-No H; Tomita N; Ando D; Miyazaki T; Izutsu KI
J Pharm Biomed Anal; 2022 Feb; 210():114561. PubMed ID: 34974238
[TBL] [Abstract][Full Text] [Related]
27. Use of autoclave extraction-supercritical fluid chromatography/tandem mass spectrometry to analyze 4-(methylintrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in tobacco.
Deng H; Tang G; Fan Z; Liu S; Li Z; Wang Y; Bian Z; Shen W; Tang S; Yang F
J Chromatogr A; 2019 Jun; 1595():207-214. PubMed ID: 30827697
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of supercritical fluid chromatography for testing of PEG adducts in pharmaceuticals.
Schou-Pedersen AM; Østergaard J; Johansson M; Dubant S; Frederiksen RB; Hansen SH
J Pharm Biomed Anal; 2014 Jan; 88():256-61. PubMed ID: 24080526
[TBL] [Abstract][Full Text] [Related]
29. Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry.
Lim HH; Oh YS; Shin HS
J Pharm Biomed Anal; 2020 Sep; 189():113460. PubMed ID: 32663759
[TBL] [Abstract][Full Text] [Related]
30. Screening approach for chiral separation of pharmaceuticals. Part III. Supercritical fluid chromatography for analysis and purification in drug discovery.
Maftouh M; Granier-Loyaux C; Chavana E; Marini J; Pradines A; Heyden YV; Picard C
J Chromatogr A; 2005 Sep; 1088(1-2):67-81. PubMed ID: 16130734
[TBL] [Abstract][Full Text] [Related]
31. MULTIPLE BCCS AND DYSPLASTIC NEVI AFTER ACE INHIBITORS (ENALAPRIL/PERINDOPRIL): THE ROLE OF NITROSAMINE CONTAMINATION/AVAILABILITY AS SUBSTANTIAL SKIN CANCER TRIGGERING FACTOR.
Tchernev G; Kordeva S
Georgian Med News; 2023 Feb; (335):90-94. PubMed ID: 37042596
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of supercritical fluid chromatography coupled to tandem mass spectrometry for pesticide residues in food.
Cutillas V; Galera MM; Rajski Ł; Fernández-Alba AR
J Chromatogr A; 2018 Apr; 1545():67-74. PubMed ID: 29496188
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a Novel LC-MS/MS Based Analytical Method for the Risk Assessment of Nitrosamines in Pharmaceutical Products and Packaging Materials.
Kartop RA; Güleli M; Faruzlu FA; Çalışkan C
J Pharm Sci; 2024 Jun; 113(6):1597-1606. PubMed ID: 38253223
[TBL] [Abstract][Full Text] [Related]
34. The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities.
Scherf-Clavel O; Kinzig M; Besa A; Schreiber A; Bidmon C; Abdel-Tawab M; Wohlfart J; Sörgel F; Holzgrabe U
J Pharm Biomed Anal; 2019 Aug; 172():278-284. PubMed ID: 31078064
[TBL] [Abstract][Full Text] [Related]
35. Purification of drug degradation products supported by analytical and preparative supercritical fluid chromatography.
Noireau A; Lemasson E; Mauge F; Petit AM; Bertin S; Hennig P; Lesellier É; West C
J Pharm Biomed Anal; 2019 Jun; 170():40-47. PubMed ID: 30904738
[TBL] [Abstract][Full Text] [Related]
36. Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals.
Horne S; Vera MD; Nagavelli LR; Sayeed VA; Heckman L; Johnson D; Berger D; Yip YY; Krahn CL; Sizukusa LO; Rocha NFM; Bream RN; Ludwig J; Keire DA; Condran G
J Pharm Sci; 2023 May; 112(5):1166-1182. PubMed ID: 36599405
[TBL] [Abstract][Full Text] [Related]
37. Optimization of a two-dimensional liquid chromatography-supercritical fluid chromatography-mass spectrometry (2D-LC-SFS-MS) system to assess "in-vivo" inter-conversion of chiral drug molecules.
Goel M; Larson E; Venkatramani CJ; Al-Sayah MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():89-95. PubMed ID: 29579733
[TBL] [Abstract][Full Text] [Related]
38. (NDMA) METFORMIN AND (NTTP) SITAGLIPTIN INDUCED CUTANEOUS MELANOMAS: LINKS TO NITROSOGENESIS, NITROSO-PHOTOCARCINOGENESIS, ONCOPHARMACOGENESIS AND THE METABOLIC REPROGRAMMING.
Tchernev G; Broshtilova V
Georgian Med News; 2024 Mar; (348):132-143. PubMed ID: 38807407
[TBL] [Abstract][Full Text] [Related]
39. Coupling state-of-the-art supercritical fluid chromatography and mass spectrometry: from hyphenation interface optimization to high-sensitivity analysis of pharmaceutical compounds.
Grand-Guillaume Perrenoud A; Veuthey JL; Guillarme D
J Chromatogr A; 2014 Apr; 1339():174-84. PubMed ID: 24656541
[TBL] [Abstract][Full Text] [Related]
40. Applications of supercritical fluid chromatography-tandem mass spectrometry in pharmaceuticals.
Bosch ME; Sánchez AJ; Rojas FS; Ojeda CB
Curr Drug Discov Technol; 2009 Sep; 6(3):214-29. PubMed ID: 19496749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
